Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Prota Therapeutics Achieves Peanut Allergy Treatment Milestone: Groundbreaking Clinical Trial Data Demonstrates Clinical Remission of Peanut Allergy in Paediatric Patients 2022-02-09 20:00
Security Matters Limited Streamlines Compliance with UK's Plastic Packaging Tax 2022-02-09 18:20
Sedgwick University expands world-class training to Australia 2022-02-08 07:30
Novari Health Launches Surgical Overdues Management HUB Technology in Response to COVID-19 Crisis 2022-02-08 04:00
IonOpticks enters OEM partnership with Bruker that sets a new standard for mass spectrometry-based research 2022-02-08 00:01
US FDA Study May Proceed letter for Clarity's Cu-64 SAR-bisPSMA trial in prostate cancer 2022-02-07 22:08
KAZIA THERAPEUTICS TO PRESENT AT BIO CEO CONFERENCE 2022-02-07 21:00
Novotech Recognized as Top 10 CRO in CenterWatch Site Relationship Benchmarking Report 2022-02-04 19:47
Splitit survey shows most prefer a Buy Now, Pay Later option on existing credit cards vs. a new line of credit 2022-02-04 09:43
Zenfolio launches new reimagined, future-forward platform in Australia 2022-02-03 03:00
Formus Labs Raises $5 Million to Automate Orthopedic Surgery Planning; Partners With Zimmer Biomet to Supercharge Global Launch 2022-02-03 03:00
Clarity advances to cohort 2 in the SARTATE™ neuroblastoma trial 2022-02-01 21:58
Sedgwick acquires Direct Health Solutions in Australia 2022-02-01 07:30
Nintex Partner Myriad Transforms Operational Intelligence Capabilities for Militaries with the Power and Security of Nintex Workflows and Forms 2022-02-01 06:05
FieldPulse and HazardCo Announce New Partnership 2022-02-01 04:48
Octopus Deploy acquires Dist to power cloud-native software deployments 2022-01-31 22:00
Cognigy Named a Leader by Gartner® in the January 2022 Magic Quadrant™ for Enterprise Conversational AI Platforms 2022-01-31 22:00
Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement 2022-01-31 19:00
Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease 2022-01-28 20:08
Appendix 4C - Q2 FY22 Quarterly Cash Flow Report 2022-01-27 20:45
1 22 23 24 25 26 113